Each year we attend a variety of conferences and events, covering a wide range of scientific fields, presenting the exciting progress and results of our ongoing breath research. Many of our recent presentations and posters are available to view online via our resources hub but here we round up the key information from the latest presentations delivered by our team for you.
IASLC (World Conference on Lung Cancer) (9th – 12th September)
Lung cancer causes close to 1.8 million deaths each year, making it the deadliest cancer worldwide (1). When cases are caught quickly, the chance of survival is much greater, with the five-year survival rate at 63% when detected at an early stage, but dropping to only 8.2% in cases where the cancer has spread to other organs (2). At Owlstone Medical, we are investigating the potential of different exhaled volatile organic compounds (VOCs) detected by our Breath Biopsy technology as biomarkers for lung cancer, with the aim to develop this as a screening method for the early detection of the disease.
The European Respiratory Society (ERS) International Congress is one of the major events for the respiratory research community, bringing together experts from across the field to explore the latest advancements in respiratory medicine and science. At the event, we presented a poster focused on research conducted with McMaster University titled ‘Investigating allergen-induced acute lung inflammation in asthmatic individuals using breath biopsies’. We also presented results from research performed in partnership with the Mayo Clinic in an oral presentation session. A peer reviewed paper on this work, titled ‘Volatile organic compounds in exhaled breath reflect physiological changes in ultramarathon runners’, has recently been published.
The Liver Meeting is an exciting event that brings together leading experts in hepatology to discuss the latest advancements in liver treatment and transplantation. Here, we presented a poster focused on ‘Gut Bacteria Phenotyping Using Dynamic Breath Analysis’. The research investigated the feasibility of quantification in breath of several gut-derived metabolites that may exacerbate diseases such as non-alcoholic steatohepatitis (NASH).
Our annual Breath Biopsy Conference is taking place on 5th and 6th November 2024. If you would like to attend or even present your research to a cohort of breath researchers, visit the conference webpages. To find out more about upcoming events being attended by Owlstone Medical and catch up on the full range of conferences that we have attended, visit our events pages.